Posts Tagged ‘DICOM-compliant’

ROCHESTER, NEW YORK, USA – February 20, 2008 – As skin cancer cases continue to rise, the worldwide deployment of In Vivo Reflectance Confocal Microscopy (RCM) (Confocal Imaging) technology – which produces digital images of a patient’s skin with cellular detail similar to that obtained from histology of surgical biopsies – can help healthcare practitioners both speed and improve their clinical judgments and assist in monitoring treatment. In support of RCM technology, the world’s first available comprehensive atlas detailing the technology has been published.

“Reflectance Confocal Microscopy of Cutaneous Tumors: An Atlas with Clinical, Dermoscopic and Histological Correlations” (Salvador González, Melissa Gill, and Allan C. Halpern, Editors; Informa Healthcare, Publisher), is a comprehensive, full-color atlas detailing the potential of RCM technology and its possible applications for clinical practitioners. The hard-cover first edition atlas totals 280-pages.

Specifically, In Vivo Reflectance Confocal Microscopy allows optical sectioning of an area of skin without physical sectioning, assisting dermatologists to examine detailed features of a skin lesion without taking a biopsy specimen. RCM technology can also assist dermatopathologists to determine the best location for a section and dermatological surgeons to determine the margins of a lesion to be excised.

The contents of “Reflectance Confocal Microscopy of Cutaneous Tumors” are:
I. BASIC PRINCIPLES
II. NORMAL SKIN
III. KERATINOCYTIC TUMORS (Seborrheic keratoses, Clear cell acanthoma, Porokeratosis, Squamous neoplasia, Basal cell carcinoma)
IV. MELANOCYTIC TUMORS (Lentigo, Congenital and common acquired melanocytic nevi, Dysplastic nevi, Malignant melanoma, Blue nevus, Spitz nevus)
V. OTHER TUMORS (Trichoepithelioma, Sebaceous hyperplasia, Dermatofibroma, Angioma, Mycosis fungoides)
VI. CLINICAL APPLICATIONS (Adjunct to clinical diagnosis, RCM-guided biopsy site selection, RCM-assisted assessment of treatment response, RCM-assisted in-vivo margin mapping, RCM-Assisted ex-vivo margin assessment)
VII. FUTURE PERSPECTIVES

The editors of the atlas are three of the world’s leading RCM medical researchers: Salvador González, M.D., Ph.D., Faculty, Dermatology, MSKCC, New York, NY, Assistant Prof, Dermatology, HMS, Boston, Mass., USA; Melissa Gill, M.D., Dermatopathologist, Quest Diagnostics Inc., Teterboro, New Jersey, USA (formerly with MSKCC, New York, NY); and Allan C. Halpern, Chief, Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY USA.

“Reflectance Confocal Microscopy of Cutaneous Tumors” (ISBN: 9780415451048) is available immediately from Informa Healthcare (http://catalogue.informahealthcare.com/) at http://catalogue.informahealthcare.com/pjbp/products/10001043243;jsessionid=2F12CE3F716298BA32B2362B147D00B6.

Lucid Inc. an RCM Leader
The leader in the development and worldwide deployment of RCM technology is Lucid, Inc. (http://www.lucid-tech.com/) of Rochester, New York, USA. Lucid is the creator of the VivaScope® reflective confocal microscopy imaging microscope and of the VivaNet®, a network-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

Atlas author Dr. González is among several European diagnostic readers providing confocal imaging services for European dermatology patients using Lucid’s VivaScope® Confocal Imagers. The readers are also beginning validation testing of Lucid’s VivaNet® telemedicine information system of transferring and managing clinical data between the private practitioners and the diagnostic readers.

For information on Lucid’s VivaScope® or VivaNet® technology, contact Lucid on the web at http://www.lucid-tech.com/, by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image

ROCHESTER, NY, USA, – February 12, 2008 – Lucid, Inc. (http://www.lucid-tech.com/) today announced the launch of its secure VivaNet® telemedicine server and network. The network is designed to transfer and manage clinical data between dermatology practitioners using Lucid’s non-invasive VivaScope® Confocal Imagers with pathologists or other medical specialists.

Lucid’s VivaScope® confocal imager microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions — without the need to excise tissue.

The VivaNet® network provides fast, accurate and secure storage, retrieval, and transfer of VivaScope images across the Internet or Lucid’s private network service. Its launch will make VivaScope® images available for review by other dermatologists and pathologists in minutes – thus enabling rapid, real-time professional collaboration.

“With VivaNet®, practitioners can rapidly receive a pathologic interpretation of confocal images from a VivaScope® session, potentially assisting physicians in arriving at a clinical judgment while a patient is still in the doctor’s office,” said Jay Eastman, CEO, Lucid Inc.

“Just as MRI and CT scans have largely eliminated the need for routine ‘exploratory surgery’, the use of the VivaNet® network in conjunction with VivaScope® confocal microscopes may one day eliminate the need for routine invasive skin biopsies,” he said.

During a typical session, once VivaScope® images are captured, they are uploaded to the secure VivaNet® server, along with other patient-related data. From there, the patient image set is immediately available for retrieval by and transfer to other authorized practitioners.

The advantages of the VivaNet® network include:

• Secure sharing of digital cellular resolution images among medical professionals
• Fast, accurate, secure information exchange to enable clinical judgments of patient skin lesions
• Rapid, near-real-time clinical reporting
• Ensured HIPAA compliance, privacy, and data integrity via DICOM-compliant, standardized medical image storage, retrieval, and transfer

The VivaNet® network has been launched for near term use by dermatologists, as users of the VivaScope® microscopes, and pathologists, as readers of VivaScope images, in the US, Europe and Australia. For more information, visit http://www.lucid-tech.com/ or call +1-585-239-9800.

About Lucid, Inc.
Lucid, Inc. (http://www.lucid-tech.com/), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope® cellular imaging technology with its innovative VivaNet® medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet® system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet® and VivaScope® are registered trademarks of Lucid, Inc.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image

ROCHESTER, NEW YORK, USA – December 11, 2007- Lucid, Inc. (http://www.lucid-tech.com/), a leading U.S. cellular imaging and technology company, has appointed Dr. Colin Stahel as Director, Asia Pacific Region.

Based in Sydney, Australia, Stahel was selected for the newly created position based on his extensive medical technology experience.

“With over twenty years of experience in the development of medical technology and pre-cancer and cancer detection equipment, Stahel is a welcome addition to the Lucid team,” said Jay Eastman, chairman and CEO of Lucid, Inc (http://www.lucid-tech.com/). “His knowledge of the field will suit his new responsibilities in the international community.”

Previously, Stahel was the senior manager with Polartechnics where he worked directly with the SolarScan digital dermatoscope and TruScreen Division for real time detection of cervical cancer, both based in Australia.

Dr. Colin D. Stahel holds a Ph.D. in physiology from the Faculty of Medicine, University of Tasmania in Australia, and a MBA from Macquarie University of Australia.

Lucid is the creator of the non-invasive VivaScope confocal microscope that provided cellular resolution images of skin, and of the VivaNet, an internet-based, DICOM-compliant medical information systems that enables the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. Lucid’s VivaScopes are in regular use throughout the United States, Europe, and Australia.

For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call 1-585-239-9800.

About Lucid, Inc.
Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. The Company’s digital VivaNetTM server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.lucid-tech.com/.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image

ROCHESTER, NEW YORK, USA – December 5, 2007 – William J. Shea has been elected to serve as Chairman of Lucid, Inc., the leading medical cellular imaging technology and information company. Shea brings a wealth of executive and financial leadership to the company, having previously served as CEO of Conseco, Vice Chairman and CFO of BankBoston and senior partner and Vice Chairman of Coopers and Lybrand (now PricewaterhouseCoopers).

As Lucid Board Chairman, Shea will be responsible for managing the Board’s business in its fiduciary role for shareholders and in its supervisory and advisory roles to the CEO and the management team of the company.

“Lucid is well positioned to transition its VivaNet technology from clinical research to routine clinical application and the company’s compelling business model is well protected by patents, both in the United States and abroad,” Shea stated. “I am looking forward to assisting the company through the exciting and challenging growth stage we envision in the next few years ahead.”

Shea, a resident of Andover, Mass., is a veteran corporate leader with a series of dramatic success stories within the financial services industry. He previously held the position of CEO of Conseco, an insurance, annuity, and financial services company. In the position, Shea increased the company’s market capitalization by more than $3.5 billion.

Before that, Shea was Vice Chairman and CFO of BankBoston where he led a fundamental restructuring that increased shareholder value tenfold.

“I am delighted that Bill Shea accepted the position of Chairman of Lucid’s Board of Directors,” said Jay Eastman, CEO of Lucid. “Bill’s experience will be invaluable resource to me and the other members of the company’s management team as we commercialize our VivaNet technology in the United States, Europe and Australia.”

Lucid (www.lucid-tech.com) is an innovative and dynamic company with a broad technology portfolio in the medical imaging and information fields. Based in Rochester, New York, the company is creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of confocal images between practitioners and pathologists for rapid review and diagnosis.

For more information, visit Lucid online at www.lucid-tech.com, by email: info@lucid-tech.com, or by phone: 585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image

ROCHESTER, NEW YORK, USA – November 19, 2007 – Lucid, Inc. (http://www.lucid-tech.com/), a leading U.S. cellular imaging and technology company, today announced the appointment of Kenneth Centola of Hilton, New York as Imaging Specialist and Christian Costa of Macedon, New York as Applications Engineer.

“Customer service is the cornerstone of Lucid’s sales and marketing policy. With the addition of Ken and Christian to the Lucid team, we are further raising the bar on our service offering,” said John Nugent, vice president of global sales and marketing for Lucid.

In the newly created position, Centola will work directly with Lucid’s VivaNet imaging sites worldwide. He will help in the creation of community based sites, train onsite imagers, and monitor ongoing performance. Centola holds a degree in Radiologic Technology from Monroe Community College in Rochester, New York, and is a licensed Radiologic Technologist by the New York State Department of Health.

Costa will work in business development for Lucid and act as a liaison with medical professionals and customers with relation to the demonstration, installation, and training of VivaScope products. Costa will also consult with engineering personnel to track customer satisfaction, product performance, and product improvements.

Lucid is the creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

For more information about Lucid and Confocal Imaging solutions, visit http://www.lucid-tech.com/ on the Web, by phone at 1-585-239-9800, or by email info@lucid-tech.com.

About Lucid Inc.
Lucid, Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNetTM system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call +1-585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image

ROCHESTER, NY – October 16, 2007 — Many routine surgical biopsies could become a thing of the past as dermatologists may soon be sharing, reviewing and diagnosing noninvasive digital images of skin cells via the Internet, using Lucid Inc.’s VivaNet™ telemedicine server and its VivaScope® confocal imagers.

The technology, which relies on using special microscopes to digitally image a patient’s skin, may bypass the need to surgically biopsy many patients. “VivaScope imaging sessions require only 5 to 10 minutes of a physician’s assistant’s time,” said Jay Eastman, Ph.D., CEO, Lucid Inc. (http://www.lucid-tech.com/.

The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.

A typical VivaScope imaging session produces two types of images of the patient’s skin: dermatoscopic-quality, full-color macroscopic pictures, and microscopic, cellular resolution images. Like a routine biopsy, the images can then be read by a dermatologist or a pathologist and the diagnosis presented to the patient.

“Just as MRI and CT scans have largely eliminated the need for routine exploratory surgery, in-vivo confocal imaging may one day eliminate the need for routine invasive skin biopsy,” Eastman stated.

Improving Quality of Life for Dermatology Patients

Already, dozens of Lucid’s VivaScopes are in regular use throughout the U.S. and Europe. “Lucid’s VivaScope® 1500 has the capability of imaging virtually all types of skin cancers, which makes it useful for many everyday procedures in a dermatology practice,” stated Dr. Harold Rabinovitz, a Florida based dermatologist who specializes in skin cancer. “The VivaScope is an incredible diagnostic tool and now routinely aids me in the clinical evaluation of potential skin cancers.”

The Company is also developing an Internet-based application, the Lucid VivaNetTM, to enable the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. The VivaNet technology conforms to DICOM (Digital Imaging and Communications in Medicine), an internationally accepted standard for the secure storage, retrieval and transfer of medical images, and it complies with federal HIPAA requirements for privacy and integrity of medical data.

Ultimately, the VivaNet could make VivaScope images available for review by other dermatologists and pathologists – anywhere in the world – in minutes, not days – thus enabling rapid, real-time professional collaboration. The ultimate goal is that practitioners will rapidly receive a pathologic interpretation of confocal images from a VivaScope session, potentially assisting the practitioner in arriving at a clinical judgment while the patient is still in the doctor’s office, Eastman said.

“It’s our hope that the VivaScope and VivaNet will improve the quality of life for dermatology patients by eliminating the need for painful, invasive skin biopsies and drastically reducing the time required for diagnosis and treatment,” Eastman said.

For information on Lucid’s VivaScope or VivaNet technology, contact Lucid by phone at 585-239-9800, by email at info@lucid-tech.com, or on the web at http://www.lucid-tech.com/.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us

Technorati tags: biopsy, biopsies, dermatology, dermatologists, actinic keratoses, field cancerisation, VivaScope, confocal microscopy, in-vivo confocal microscopy, pigmented lesion, melanoma, telemedicine server, pathologists, microscopy, DICOM, DICOM-compliant, confocal imager, cellular resolution image